We would like to inform you that due to unforeseen circumstances beyond the organizer control, the "11th Edition of Global Conference on Pharmaceutics and Novel Drug Delivery Systems" (Pharma-2024), originally scheduled for March 18-20 in Singapore, has been rescheduled to take place from September 19-21, 2024, in Rome, Italy.
If you have already confirmed your participation at the event, please note that your registration and accommodation (if previously booked with us) will automatically be transferred to the new dates.
For any further information or inquiries, please do not hesitate to contact us at firstname.lastname@example.org or call us at +1 (702) 988 2320.
Title: Next generation of drug delivery system: stimuli-sensitive combination nanopreparations.
Title: Nanoparticle Delivery of Mitochondria-Associated MicroRNA Regulating Inflammation in the Central Nervous System.
Title: Engineered spatiotemporal delivery of morphogens for skeletal regeneration.
Title: Drug screening and targeting against the stem subpopulation of cancer cells.
Title: Peptide delivery to the brain: A novel treatment for migraine.
Title: Overcoming the barriers to effective targeted drug delivery through stem cell-derived Nano-Ghosts.
Title: Physicochemical characterization of co-crystals and cyclodextrin inclusion complexes of bioactive molecules.
Title: Signaling peptides for brain diseases: Delivery and action.
Title: Impact of inhalation manoeuvre parameters on drug delivery to the Lungs from dry powder inhalers in-vitro and Ex-vivo.
Title: Poly (vinyl pyrrolidone) Nanofibers as Drug Delivery of Sildenafil Citrate.
Title: Understanding the Impact of Nanoparticle Structure on Cellular Response.
Title: 5-Tiered (pre-) formulation approach to support toxicology studies.
Title: Challenges of in vitro drug release testing from advanced mucosal formulations.
Title: Chimeric and Multicompartment Drug Delivery Systems: Lessons learned and future perspectives.
Title: Lipid based parenteral depots for biomolecules, an update on recent work.
Title: Computational blind docking of ligands to drug targets: methodology and applications.
Title: The influence of gut microbiota-mediated bile acid metabolism on the cellular response to therapeutics at the intestinal barrier.
Title: Cyclodextrin-based photoactive liposomal nanoparticles for tumor targeting.
Title: Getting health allies from agriculture enemies: plant viruses as smart nanoparticles for vaccine/drug delivery.
Title: New aerosol treatment for human nasal cavity through numerical simulation.
Title: Porous biodegradable particles for efficient transfollicular drug delivery.
Title: Polyethyleneimine-simvastatin nanoparticles loaded PANi/chitosan-gelatin scaffolds as drug delivery for osteogenesis.
Title: Case presentation: Patient with metastatic pancreatic adenocarcinoma treated with nanoliposomal irinotecan combination therapy.
Title: Polyethylenimine-based nanoparticles decorated with small molecules mimicking RGD peptide for targeted plasmid DNA delivery.
Title: Brain targeted nanotherapeutics: an enticing journey from ideation to product realization.
Title: Cyclic GMP-AMP: A new hope for metabolic disease?
Title: Characterization of lactose carrier for dry powder inhaler formulations.
Title: Casein-based nanovehicles for oral delivery of chemotherapeutic combinations to overcome multidrug resistance in gastric cancer.
Title: Delivery of siRNA in vivo to the liver using redox sensitive and ionizable lipids.
Title: The Competitive binding Studies of CMP Inhibitor and Polysialic Acid (polySia) to the Polybasic Polysialyltransferase Domain (PSTD) in the Polysialyltransferase.
Title: New potential nanotechnology-based therapy with novel Gal-3 inhibitor for the treatment of rheumatoid arthritis.
Title: The effects of drug encapsulation into gellan gum matrix by the example of roxithromycin, naproxen and meloxicam.
Title: Active loading of resveratrol in transferrin-functionalised liposomes using a pH gradient technique.
Title: Myometrium-targeted liposomes for prevention of preterm labor.
Title: Use of an inflating agent to engineer novel lactose carrier for inhalation and drug deposition in-vitro using three model drugs: salbutamol, beclomethasone and fluticasone.
Title: Novel RNA-carbohydrate conjugates for modulation of LDLR and cholesterol by transcriptional silencing.
Title: Synthesis and cytotoxicity studies on novel piperazinylacetamides.
Title: HEA-HEMA hydrogels: Composition effect on physicochemical and pharmaceutical properties.
Title: Targeting nanomedicine to the vascular endothelium.
Title: EAAT3 proteins as a pharmacological target for the design of new antiepileptic drugs.
Title: Microbiological pharmaceutical analysis: Better safe than sorry.